CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
BioCopy has developed a patented method for copying biomolecules, enabling rapid analysis for drug development and diagnostics. This technology aims to streamline the discovery of vaccine candidates and other therapeutic applications, significantly impacting the biotechnology sector.
BioCopy is a spin-off company borned in the University of Freiburg.
We have developed an innovative, patented technique to copy biomolecules analogous to a photocopier. A DNA-coated surface is used as copy template.
By supplying different biochemical ""copy mixes"", either a DNA, a RNA or a protein copy is generated.
After the copy process, the copied biomolecules can be analyzed label-free for their specific binding to target molecules and recovered as potential candidates for a future use as t…
BIOCOPY GMBH
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
